PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts

Edward Jenkins1,2,3, Martin Fellermeyer1,2,4, Daniel F Heraghty5

  • 1Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Science Immunology
|May 15, 2026
PubMed

Insights

Programmed cell death protein 1 (PD-1) limits T cell receptor (TCR) signaling duration at microvillar contacts. This discovery offers a framework for enhancing cancer immunotherapy efficacy.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Background:

  • Lymphocyte activation integrates signals from multiple receptors at cell-cell contacts.
  • The spatiotemporal regulation of immune cell signaling integration remains poorly understood.

Purpose of the Study:

  • To investigate the spatiotemporal integration of programmed cell death protein 1 (PD-1) and T cell receptor (TCR) signaling.
  • To elucidate the role of microvillar contacts in immune signal integration.

Main Methods:

  • Live-cell imaging of T cell-target cell interactions.
  • Analysis of PD-1 and TCR signaling dynamics.
  • Biochemical assays involving SHP2 recruitment.
  • Engineering of PD-1 blocking antibodies.

Main Results:

  • PD-1 and TCR signals integrate at nanoscale microvillar contacts.
  • PD-1 signaling limits the duration, not amplitude, of TCR signaling.
  • PD-1 suppresses TCR activity by recruiting SHP2 and reducing cell spreading and TCR engagement.
  • Antibody engineering to prevent PD-1 trapping improved blockade efficacy.

Conclusions:

  • Microvillar contacts are critical hubs for initial immune signal integration.
  • Understanding PD-1/TCR interaction dynamics at contacts optimizes checkpoint immunotherapies.
  • Targeted antibody design can enhance the efficacy of PD-1 blockade.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...